Jesus Soberino
- 4.4 Good • 6 reviews
- 18 years of experience
- accreditation:
- Spain, Barcelona, Hospital Quiron Barcelona
Leader in immunotherapy research for melanoma and breast cancer – Dr. Soberino has contributed to groundbreaking drug approvals that revolutionized treatment.
- Key participant in trials leading to Pembrolizumab and Nivolumab-Ipilimumab approvals
- Specializes in overcoming hormone therapy resistance in breast cancer
- Active researcher in phase 1-3 clinical trials for new treatments
- Member of Vall d'Hebron's specialized Breast Cancer and Melanoma Units
- Read more